Superantigen

Definition

A superantigen (SAg) is a microbial protein toxin that acts as a polyclonal stimulator of T cells by binding outside the normal peptide-binding groove of MHC class II molecules. Unlike conventional antigens - which activate only ~0.001-0.01% of T cells - superantigens can activate up to 20% of the entire circulating T-cell pool simultaneously, producing a massive cytokine storm.

Mechanism - How Superantigens Work

Normal antigen presentation (for comparison):

An antigen is taken up by an antigen-presenting cell (APC)
It is proteolytically processed into peptide fragments
Peptides are loaded into the groove of MHC class II
The TCR's CDR3 region recognizes the specific peptide-MHC complex
Only T cells with the exact right TCR are activated (~0.001% of T cells)

Superantigen mechanism (bypasses all of this):

The SAg binds intact (no processing needed) directly to conserved amino acid residues outside the antigen-binding groove of MHC class II
It simultaneously crosslinks to the Vβ domain of the TCR (not the CDR3 region)
This non-specific crosslinking activates all T cells bearing a particular Vβ gene segment - regardless of their antigen specificity
Massive simultaneous activation of 5-20% of T cells ensues
This triggers enormous cytokine release (IL-1, IL-2, TNF-α, IFN-γ), leading to systemic effects

Superantigen exotoxin binding MHC class II outside the groove and crosslinking the TCR Vβ chain - Sherris & Ryan's Medical Microbiology

Figure: The superantigen (orange/yellow) wedges between the MHC class II molecule (on the APC) and the TCR Vβ chain (on the T cell), bypassing normal peptide-specific recognition and triggering cytokine release.

Molecular structure of superantigen SEB bound to MHC and TCR - Roitt's Essential Immunology

Figure: (a) Crystal structure of staphylococcal enterotoxin B (SEB) wedged between MHC α/β chains and TCR Vβ chain. (b) Schematic showing the superantigen bridging MHC and TCR outside the normal peptide groove.

Key Properties

Feature	Conventional Antigen	Superantigen
Antigen processing required?	Yes	No
Binds MHC II	In peptide groove	Outside groove
TCR region bound	CDR3 (specific)	Vβ domain (non-specific)
% T cells activated	0.001-0.01%	5-20%
Cytokine release	Normal/regulated	Massive (cytokine storm)

Examples of Superantigens

Staphylococcus aureus (most clinically important):

TSST-1 (Toxic Shock Syndrome Toxin 1) - causes menstrual and non-menstrual toxic shock syndrome
Staphylococcal Enterotoxins A-C (SEA, SEB, SEC) - cause food poisoning and TSS
There are now >15 described staphylococcal SAgs; less than 20% of S. aureus strains produce any SAg

Streptococcus pyogenes (Group A Strep):

Streptococcal pyrogenic exotoxins (SPE A, B, C) - cause streptococcal TSS and scarlet fever

Viral:

Some viral proteins (e.g., mouse mammary tumor virus proteins) act as superantigens
HIV gp120 acts as a B-cell superantigen (see below)

B-Cell Superantigens

Some superantigens activate B cells instead of (or in addition to) T cells. For example:

Staphylococcal protein A reacts with the Fc region of IgG and with 15-50% of antibodies that use the VH3 gene family
HIV gp120 also cross-reacts with VH3 family immunoglobulins These polyclonally activate B cells without specific antigen recognition.

Clinical Consequences

The massive cytokine release (cytokine storm) from superantigen activation causes:

Toxic Shock Syndrome (TSS) - fever, hypotension, multi-organ failure

Staphylococcal TSS: classically from tampon use (TSST-1), or skin/wound infections
Streptococcal TSS: from invasive GAS infections

Food poisoning - staphylococcal enterotoxins cause rapid-onset vomiting (the toxin is heat-stable, surviving boiling, and stimulates the brain stem emetic center via the vagus nerve)
Kawasaki disease - the superantigen model proposes TSST-1 may trigger the massive immune activation seen in this pediatric vasculitis
Nasal polyposis - staphylococcal SAgs have been proposed to drive type 2 inflammation and nasal polyp formation in Caucasian patients

Key T-Cell Consequences After Activation

After the initial massive proliferation:

Activated T cells eventually undergo activation-induced cell death (AICD) or anergy
This leads to a long-term deletion of T cells expressing the superantigen-reactive Vβ chains - a form of peripheral tolerance induction (exploited experimentally)

Sources:

Sherris & Ryan's Medical Microbiology, 8th Edition, pp. 893, 968-969
Roitt's Essential Immunology, Figure 5.29
Goldman-Cecil Medicine, Superantigen Model (Kawasaki disease / vasculitis chapter)

This is a shared conversation. Sign in to Orris to start your own chat.